Compound News and Research

RSS

New oligomer shows promising anti-SARS-CoV-2 properties

Scientists from the University Of New Mexico have recently identified a new cationic oligomer that may help inactivate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

20 Oct 2021

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

A group of researchers performed a drug repurposing screen on an FDA-approved anti-cancer drug named Mitoxantrone.

20 Oct 2021

Infrared light therapy may potentially benefit people with dementia

Infrared light therapy might have the potential to help people living with dementia, according to researchers.

19 Oct 2021

100% orange juice shows potential to help fight inflammation and oxidative stress

A new study suggests 100% orange juice has the potential to help fight inflammation and oxidative stress in adults, paving the way for further research on the topic.

19 Oct 2021

Scientists scan 110 natural compounds for SARS-CoV-2 antiviral potential

Phytochemicals are plant-derived molecules from medicinal plants that act as a prominent reservoir for treating a wide range of viral infections. In a new study, published in the journal Scientific Reports, scientists adopted a computational approach to identify Mpro inhibitors.

19 Oct 2021

FDA-approved drug encourages sensory neurons to regrow after injury

A spinal cord injury damages the lines of communication between the body and brain, impeding the signals that drive movement and sensation.

18 Oct 2021

Johns Hopkins Medicine awarded NIH grant to explore the impacts of psilocybin on tobacco addiction

Johns Hopkins Medicine was awarded a grant from the National Institutes of Health (NIH) to explore the potential impacts of psilocybin on tobacco addiction.

18 Oct 2021

Network enabled remote sample management

DP5 Network is the latest version of Ziath's market leading 2D rack decoding web browser software designed to unchain scientists from their lab bench.

From Ziath Ltd 18 Oct 2021

New class of CXCR4 antagonists could prevent airway inflammation and atopic dermatitis

Aberrant CXCR4/CXCL12 signaling is involved in many pathophysiological processes such as cancer and inflammatory diseases. A natural fragment of serum albumin, named EPI-X4, has previously been identified as endogenous peptide antagonist andinverse agonistof CXCR4 and is a promising compound for the development of improved analogues for the therapy of CXCR4-associated diseases.

18 Oct 2021

Generating Cell Repellent Surfaces in Microfluidic Devices

AMSBIO report that researchers from the Medical University of Vienna (Austria), have used Lipidure® - CM5206 to coat channels in their novel microfluidic devices, to prevent cell adhesion.

From AMS Biotechnology 15 Oct 2021

New wearable and noninvasive device created for less intrusive glucose monitoring

Noninvasive glucose monitoring devices are not currently commercially available in the United States, so people with diabetes must collect blood samples or use sensors embedded under the skin to measure their blood sugar levels.

15 Oct 2021

Fraunhofer researchers investigate how viruses can be efficiently eliminated from indoor air

How can viruses be effectively eliminated from indoor air? This question is now becoming more important as fall approaches. Efficient indoor air purification is essential, especially in schools.

13 Oct 2021

FSU chemists develop a faster way to synthesize compounds for drug development

A team of Florida State University chemists has developed a faster way to synthesize a class of compounds that are commonly used in the development of new medications.

12 Oct 2021

A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo

The team has evaluated a low molecular weight chitosan derivative as a candidate preventing the viral entry into mammalian nasal epithelial cells to limit the spread of COVID-19.

12 Oct 2021

New compound can prevent SARS-CoV-2 and related coronaviruses from entering cells

Scientists at Washington University School of Medicine in St. Louis have developed a compound that prevents SARS-CoV-2 and related coronaviruses from entering cells.

11 Oct 2021

The role of inhibiting palmitoylation of the SARS-CoV-2 spike protein on viral infectivity

It is demonstrated that palmitoylation of the first five cysteine residues of the C-terminal domain of the SARS-CoV-2 spike protein facilitates cell entry and the formation of syncytia.

11 Oct 2021

Lipids, COVID-19, and host immunity

A new study from a team of researchers at the University of Pennsylvania examines the role played by lipids in this disease.

10 Oct 2021

TTUHSC investigator evaluates the potential of neurolysin as a therapeutic target for stroke

Ischemic stroke, the second leading cause of death worldwide, occurs when a vessel to the brain is blocked, reducing blood flow to the brain and depriving it of critical supplies of oxygen and nutrients.

8 Oct 2021

KU Leuven researchers develop an ultrapotent inhibitor of dengue virus

Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue.

6 Oct 2021

Enisamium shows potential as antiviral therapy for COVID-19

Researchers studied the effect of enisamium on the growth and proliferation of Caco-2 and normal human bronchial epithelial cells.

6 Oct 2021

Compound News and Research

New oligomer shows promising anti-SARS-CoV-2 properties

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

Infrared light therapy may potentially benefit people with dementia

100% orange juice shows potential to help fight inflammation and oxidative stress

Scientists scan 110 natural compounds for SARS-CoV-2 antiviral potential

FDA-approved drug encourages sensory neurons to regrow after injury

Johns Hopkins Medicine awarded NIH grant to explore the impacts of psilocybin on tobacco addiction

Network enabled remote sample management

New class of CXCR4 antagonists could prevent airway inflammation and atopic dermatitis

Generating Cell Repellent Surfaces in Microfluidic Devices

New wearable and noninvasive device created for less intrusive glucose monitoring

Fraunhofer researchers investigate how viruses can be efficiently eliminated from indoor air

FSU chemists develop a faster way to synthesize compounds for drug development

A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo

New compound can prevent SARS-CoV-2 and related coronaviruses from entering cells

The role of inhibiting palmitoylation of the SARS-CoV-2 spike protein on viral infectivity

Lipids, COVID-19, and host immunity

TTUHSC investigator evaluates the potential of neurolysin as a therapeutic target for stroke

KU Leuven researchers develop an ultrapotent inhibitor of dengue virus

Enisamium shows potential as antiviral therapy for COVID-19

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News